The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor
The advanced, metastasis, and reccurent of osteosarcoma (OS) patients have a poor prognosis postaggresive surgery and chemotherapy. Peripheral blood mononuclear cells (PBMCs) as cell-based immunotherapy may successful in the OS treatment. To investigate the enhancement apoptosis of OS-mesenchymal st...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Advanced Pharmaceutical Technology & Research |
Subjects: | |
Online Access: | http://www.japtr.org/article.asp?issn=2231-4040;year=2020;volume=11;issue=4;spage=213;epage=219;aulast=Mahyudin |
id |
doaj-6148fb4fa3d847bbad50d316260a5dae |
---|---|
record_format |
Article |
spelling |
doaj-6148fb4fa3d847bbad50d316260a5dae2020-11-25T03:34:13ZengWolters Kluwer Medknow PublicationsJournal of Advanced Pharmaceutical Technology & Research2231-40400976-20942020-01-0111421321910.4103/japtr.JAPTR_52_20The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factorFerdiansyah MahyudinHizbillah YazidMouli EdwardMohammad Hardian BasukiYunus Abdul BariFedik Abdul RantamThe advanced, metastasis, and reccurent of osteosarcoma (OS) patients have a poor prognosis postaggresive surgery and chemotherapy. Peripheral blood mononuclear cells (PBMCs) as cell-based immunotherapy may successful in the OS treatment. To investigate the enhancement apoptosis of OS-mesenchymal stem cells (OS-MSCs) co-cultivated with PBMCs sensitized using the secretome and granulocyte macrophage colony-stimulating factor (GMCSF). This true experimental study with posttest only control group design and in vitro study. The sample was cultured OS-MSCs which confirmed by Cluster of Differentiation-133 using immunocytochemistry (ICC) and histopathology analysis. The sample divided into six groups accordingly: OS-MSC, OS-MSC + PMBC, OS-MSC + PMBC + Secretome, OS-MSC + PMBC + GMCSF, OS-MSC + PBMC + Secretome + GMCSF (n = 5/N = 30). The enhancement of OS-MSCs apoptosis was analyzed through Interleukin-2 (IL-2) level through the Enyzme-Linked Immunosorbent Assay examination, expression of Signal Transducers and Activators of Transcription (STAT)-3 and caspase-3 by ICC. One-way analysis of variance test and Tukey Honestly Significant Difference to analyze the difference between the groups (P < 0.05). The highest of IL-2 level was found in the PBMC + Secretome + GMCSF group. The highest expression of caspase-3 was found in OS-MSC + PBMC + Secretome + GMCSF group with significant different between groups (P < 0.05). There was insignificant difference of STAT-3 epxression and IL-2 level between groups (P > 0.05). The co-cultivation of OS-MSCs and PBMSCs activated using secretome and GMCSF has a great ability to enhance OS-MSCs apoptosis.http://www.japtr.org/article.asp?issn=2231-4040;year=2020;volume=11;issue=4;spage=213;epage=219;aulast=Mahyudingranulocyte macrophage colony stimulating factormesenchymal stem cellsosteosarcomaperipheral blood mononuclear cellssecretome |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ferdiansyah Mahyudin Hizbillah Yazid Mouli Edward Mohammad Hardian Basuki Yunus Abdul Bari Fedik Abdul Rantam |
spellingShingle |
Ferdiansyah Mahyudin Hizbillah Yazid Mouli Edward Mohammad Hardian Basuki Yunus Abdul Bari Fedik Abdul Rantam The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor Journal of Advanced Pharmaceutical Technology & Research granulocyte macrophage colony stimulating factor mesenchymal stem cells osteosarcoma peripheral blood mononuclear cells secretome |
author_facet |
Ferdiansyah Mahyudin Hizbillah Yazid Mouli Edward Mohammad Hardian Basuki Yunus Abdul Bari Fedik Abdul Rantam |
author_sort |
Ferdiansyah Mahyudin |
title |
The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor |
title_short |
The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor |
title_full |
The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor |
title_fullStr |
The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor |
title_full_unstemmed |
The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor |
title_sort |
enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Advanced Pharmaceutical Technology & Research |
issn |
2231-4040 0976-2094 |
publishDate |
2020-01-01 |
description |
The advanced, metastasis, and reccurent of osteosarcoma (OS) patients have a poor prognosis postaggresive surgery and chemotherapy. Peripheral blood mononuclear cells (PBMCs) as cell-based immunotherapy may successful in the OS treatment. To investigate the enhancement apoptosis of OS-mesenchymal stem cells (OS-MSCs) co-cultivated with PBMCs sensitized using the secretome and granulocyte macrophage colony-stimulating factor (GMCSF). This true experimental study with posttest only control group design and in vitro study. The sample was cultured OS-MSCs which confirmed by Cluster of Differentiation-133 using immunocytochemistry (ICC) and histopathology analysis. The sample divided into six groups accordingly: OS-MSC, OS-MSC + PMBC, OS-MSC + PMBC + Secretome, OS-MSC + PMBC + GMCSF, OS-MSC + PBMC + Secretome + GMCSF (n = 5/N = 30). The enhancement of OS-MSCs apoptosis was analyzed through Interleukin-2 (IL-2) level through the Enyzme-Linked Immunosorbent Assay examination, expression of Signal Transducers and Activators of Transcription (STAT)-3 and caspase-3 by ICC. One-way analysis of variance test and Tukey Honestly Significant Difference to analyze the difference between the groups (P < 0.05). The highest of IL-2 level was found in the PBMC + Secretome + GMCSF group. The highest expression of caspase-3 was found in OS-MSC + PBMC + Secretome + GMCSF group with significant different between groups (P < 0.05). There was insignificant difference of STAT-3 epxression and IL-2 level between groups (P > 0.05). The co-cultivation of OS-MSCs and PBMSCs activated using secretome and GMCSF has a great ability to enhance OS-MSCs apoptosis. |
topic |
granulocyte macrophage colony stimulating factor mesenchymal stem cells osteosarcoma peripheral blood mononuclear cells secretome |
url |
http://www.japtr.org/article.asp?issn=2231-4040;year=2020;volume=11;issue=4;spage=213;epage=219;aulast=Mahyudin |
work_keys_str_mv |
AT ferdiansyahmahyudin theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT hizbillahyazid theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT mouliedward theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT mohammadhardianbasuki theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT yunusabdulbari theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT fedikabdulrantam theenhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT ferdiansyahmahyudin enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT hizbillahyazid enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT mouliedward enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT mohammadhardianbasuki enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT yunusabdulbari enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor AT fedikabdulrantam enhancementapoptosisofosteosarcomamesenchymalstemcellscocultivationwithperipheralbloodmononuclearcellssensitizedbysecretomeandgranulocytemacrophagecolonystimulatingfactor |
_version_ |
1724559866626834432 |